Every SEC Form 3/4/5 on record for this filer (CIK 1814238) — 4 issuers, 12 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| RPRX | Royalty Pharma plc | EVP & Chairman, Partnering | 2020-06-15 → 2026-06-25 | 12 | −$6M |
| KLRA | Kailera Therapeutics, Inc. | Director | 2026-04-16 → 2026-04-20 | 2 | — |
| VERA | Vera Therapeutics, Inc. | Director | 2026-03-09 → 2026-03-09 | 2 | — |
| XLRN | ACCELERON PHARMA INC | Director · lapsed | 2020-06-05 → 2021-11-22 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| RPRX | 2026-06-23 | Sell | 32,408 | $54.11 | $2M | 676,991 |
| RPRX | 2026-06-23 | Sell | 117,592 | $54.47 | $6M | 559,399 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.